tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Charles Duncan, 418 are a BUY (90.28%), 41 are a HOLD (8.86%), 4 are a SELL (0.86%).
Analyst Charles Duncan, carries an average stock price target met ratio of 49.32% that have a potential upside of 50.37% achieved within 312 days. Previously, Charles Duncan worked at CANTOR FITZGERALD.
Charles Duncan’s has documented 902 price targets and ratings displayed on 66 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on CMPS, Compass Pathways Plc at 28-Mar-2025.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 3/3/2020. The price target of $144 was fulfilled within 3 days with a profit of $54.6 (61.07%) receiving and performance score of 203.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Oct-2023
$40
$13.16 (49.03%)
$39
24 days ago
(06-Jan-2026)
2/6 (33.33%)
$13.85 (52.96%)
467
Hold Since 09-May-2024
$29
$2.16 (8.05%)
$24
1 months 28 days ago
(02-Dec-2025)
10/14 (71.43%)
$3.57 (14.04%)
157
Buy Since 10-Oct-2023
$31
$4.16 (15.50%)
$33
2 months 13 days ago
(17-Nov-2025)
8/14 (57.14%)
$6.98 (29.06%)
113
Buy Since 28-Feb-2024
$29
$2.16 (8.05%)
$28
2 months 24 days ago
(06-Nov-2025)
5/11 (45.45%)
$7.35 (33.95%)
312
Buy Since 23-Jun-2025
$32
$5.16 (19.23%)
$40
2 months 24 days ago
(06-Nov-2025)
0/3 (0%)
$10.35 (47.81%)
What Year was the first public recommendation made by Charles Duncan?
